showed a trendp=0.021
Similarly, RFS also showed a trend towards better outcomes for female patients across all stages, with a statistically significant improvement in stage 2 (76.4% vs. 88.1%, p=0.021) ( Fig. 3 ).
Similarly, RFS also showed a trend towards better outcomes for female patients across all stages, with a statistically significant improvement in stage 2 (76.4% vs. 88.1%, p=0.021) ( Fig. 3 ).
Therefore, the analysis of sex differences in our study, with a predominance of SCC cases, is considered highly significant.